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A 29-year-old Ugandan woman presented with a 
4-week history of fever and headache. She had felt 
nauseous at times but had not vonlitecl. Her husband 
had observed that over the previous week she had 
become much more lethargic and forgetful. She was 
not complaining of photophobia or neck stiffness, 
but had had some problems with blurred vision. 
She had arrived in the UK 4 months ago, as her 
8-month-old child was unwell and had not been 
responding to treatment in her home country. He had 
since been diagnosed as being HIV positive 
O n  examination she was thin and her temperature 
was 38.1OC. She was fully orientated and examination 
of her niental state was normal. There was no nuchal 
rigidity and Kernig's sign was negative. There were no 
focal abnormalities on examination of the nervous 
system. Investigations included a normal C T  scan of the 
head and the following cerebrospinal fluid results; pro- 
tein 0.61 g/L, glucose 2.2 mmol/L, white cells 98/mL 
(90% lymphocytes; 5% neutrophils; 5% degenerate), 
red cells 360/mL, Gram stain-see above. 
Questions 
1. Describe the Gram stain of the cerebrospinal fluid. 
2. What is the likely cause of her presenting illness? 
3. What is the best test to rapidly confirm this? 
4. Five days after commencing treatment, her condition 
deteriorated. Over a 24-h period she became more 
confused and drowsy, and eventually lost conscious- 
ness. O n  examination she was afebrile, but was 
noted to have a left VIth nerve palsy What com- 
plication had arisen? 
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Answers 
1. The Gram stain shows Gram-positive, yeast-like 
2. Meningitis due to Cryptococcus neojormans (secondary 
3.  Testing of blood or cerebrospinal fluid for crypto- 
4. She has developed raised intracranial pressure (the 
organisms. 
to HIV infection). 
coccal antigen. 
VIth nerve palsy is a false localizing sign). 
Discussion 
Cryptococcus neoformans is an important opportunistic 
pathogen in patients with the acquired immune 
deficiency syndrome (AIDS), and cryptococcal infec- 
tions, particularly meningitis, occur in 5-10% of these 
patients. Based on differential expression of the poly- 
saccharide capsular antigen, four serotypes (A-D) of the 
organism can be distinguished. Two varieties, based on 
biochemical testing, are also recognized; Cvyptocorcus 
neojormans var. neojormans (which includes serotypes A 
and D) and Cvyptoroccus neofovmans var. gatti (which 
includes serotypes B and C). The vast majority of cases 
of cryptococcal meningitis associated with AIDS are 
due to Cryptococcus neojovmans var. neojormans serotype 
A. Central nervous system infection in these patients 
usually presents as a subacute meningitidmeningo- 
encephalitis with lethargy, fever, headache, personality 
changes, confusion and memory loss occurring over 
a 2-4-week period. Signs of meningism and focal 
neurologic signs are present in less than 5% of cases. 
In AIDS patients, involvement of a secondary site, 
usually lung, skin or blood, is relatively common. 
Infection in patients with AIDS is usually 
associated with high numbers of organisms and these 
may be seen on Gram staining of the cerebrospinal 
fluid (CSF). However, the conventional method of 
visualization is by India ink staining of CSF, which will 
demonstrate the encapsulated organism in -50% cases. 
The most sensitive and specific rapid diagnostic test is 
the detection of cryptococcal polysaccharide capsular 
antigen in CSF or blood, and this test is positive in 
90-95% of cases. The definitive diagnosis is made by 
culture, and in primary cryptococcal meningitis the 
organism can normally be grown from the CSF. 
Although not proved by large comparative trials, it 
is generally recommended that the initial treatment of 
cryptococcal meningitis should be with amphotericin 
B with or without flucytosine. As patients with AIDS 
often require prolonged treatment, early therapy with 
amphotericin B (which gives rapid clearance of the 
organism) is often followed by a triazole such as 
fluconazole or itraconazole. Such regimens have been 
successful in reducing mortality in this patient group. 
Although there has been some success in treating 
AIDS-associated cryptococcal meningitis with azole 
monotherapy, response rates are only 50-60%. 
Cryptococcal meningitis in patients with AIDS inevitably 
relapses once treatment is discontinued, and recent 
evidence suggests that fluconazole is superior to 
itraconazole for long-term maintenance suppressive 
therapy. Although prophylactic triazoles do reduce the 
incidence of both cryptococcal disease and mucosal 
candidiasis in AIDS patients (especially if the CD4 
count is less than 50/mL), prophylaxis is not generally 
recommended in view of lack of survival benefit and 
the risk of selection of fluconazole-resistant Candida 
species. 
A recognized complication of cryptococcal nienin- 
gitis is raised intracranial pressure, which can occur 
in the absence of cerebral edema. Sudden increases of 
intracranial pressure can lead to rapid clinical deteriora- 
tion and death, and as the CT scan often appears 
normal in the early stages, this complication is easily 
overlooked. The majority of patients will respond 
to therapeutic lumbar puncture and, although this 
procedure may need to be repeated, the condition 
usually resolves once the underlying infection is con- 
trolled. A few patients may require the insertion of a 
temporary ventricular shunt or lumbar drain. Although 
corticosteroids and acetazolamide (which reduces the 
production of CSF) have been used in the management 
of patients with raised intracranial pressure, the use of 
these agents is not routinely recommended. 
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